APOBEC3 enzymes restrict marginal zone B cells

European Journal of Immunology

Volumn 45, Issue 3, 2015, Pages 695-704

  Beck Engeser, Gabriele B ^a   Winkelmann, Rebecca ^b   Wheeler, Matthew L ^a   Shansab, Maryam ^a   Yu, Philipp ^c   Wünsche, Sarah ^c   Walchhütter, Anja ^c   Metzner, Mirjam ^a,b   Vettermann, Christian ^b   Eilat, Dan ^d   Defranco, Anthony ^a   Jäck, Hans Martin ^b   Wabl, Matthias ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Apobec3; B cell; Hitchhiker 1; Recovery from Friend virus 3 (Rfv3); Sialyl transferases

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; B CELL ACTIVATING FACTOR; HITCHHIKER 1 PROTEIN; PROTEIN; SIALYL TRANSFERASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; APOBEC3 PROTEIN, HUMAN; APOBEC3 PROTEIN, MOUSE; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL MATURATION; CELL POPULATION; CELL SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; ENZYME ACTIVITY; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROPOSON; STEADY STATE; T LYMPHOCYTE; VIREMIA; WILD TYPE; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; GERMINAL CENTER; HUMANS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; VIRUS DISEASES;

EID: 84924514309     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445218     Document Type: Article

References (31)

1. Refsland, E. W. and Harris, R. S., The APOBEC3 family of retroelement restriction factors. Curr. Top. Microbiol. Immunol. 2013. 371: 1-27.
2. Langlois, M. A., Kemmerich, K., Rada, C. and Neuberger, M. S., The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3. J. Virol. 2009. 83: 11550-11559.
3. Chiu, Y. L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T. et al., High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl. Acad. Sci. USA 2006. 103: 15588-15593.
4. Muckenfuss, H., Hamdorf, M., Held, U., Perkovic, M., Lower, J., Cichutek, K., Flory, E. et al., APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 2006. 281: 22161-22172.
5. Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., O'Shea, K. S., Moran, J. V. and Cullen, B. R., Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. USA 2006. 103: 8780-8785.
6. Stenglein, M. D. and Harris, R. S., APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem 2006. 281: 16837-16841.
7. Metzner, M., Jäck, H.-M. and Wabl, M., LINE-1 retroelements complexed and inhibited by AID. PLoS ONE 2012. 7: e49358.
8. Boi, S., Kolokithas, A., Shepard, J., Linwood, R., Rosenke, K., Van Dis, E., Malik, F. et al., Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase. J. Virol. 2014. 88: 7659-7662.
9. Santiago, M. L., Montano, M., Benitez, R., Messer, R. J., Yonemoto, W., Chesebro, B., Hasenkrug, K. J. et al., Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 2008. 321: 1343-1346.
10. Takeda, E., Tsuji-Kawahara, S., Sakamoto, M., Langlois, M. A., Neuberger, M. S., Rada, C. and Miyazawa, M., Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. J. Virol. 2008. 82: 10998-11008.
11. Halemano, K., Guo, K., Heilman, K. J., Barrett, B. S., Smith, D. S., Hasenkrug, K. J. and Santiago, M. L., Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. Proc. Natl. Acad. Sci. USA 2014. 111: 7759-7764.
12. Smith, D. S., Guo, K., Barrett, B. S., Heilman, K. J., Evans, L. H., Hasenkrug, K. J., Greene, W. C. et al., Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. PLoS Pathog. 2011. 7: e1002284.
13. Cerutti, A., Cols, M. and Puga, I., Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat. Rev. Immunol. 2013. 13: 118-132.
14. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H. and Kearney, J. F., Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 1997. 27: 2366-2374.
15. Pillai, S., Cariappa, A. and Moran, S. T., Marginal zone B cells. Annu. Rev. Immunol. 2005. 23: 161-196.
16. Pillai, S. and Cariappa, A., The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 2009. 9: 767-777.
17. Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S. J. and Malim, M. H., Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 2004. 14: 1392-1396.
18. Doehle, B. P., Schafer, A., Wiegand, H. L., Bogerd, H. P. and Cullen, B. R., Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 2005. 79: 8201-8207.
19. Kozak, C. A., Viewpoint on Emv2, the onlhy endogenous ecotropic murine leukemia virus of C57BL/6 mice. Retrovirology 2012. 9: 25.
20. Young, G. R., Eksmond, U., Salcedo, R., Alexopoulou, L., Stoye, J. P. and Kassiotis, G., Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 2012. 491: 774-778.
21. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T. et al., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002. 3: 196-200.
22. Yu, P., Lubben, W., Slomka, H., Gebler, J., Konert, M., Cai, C., Neubrandt, L. et al., Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity 2012. 37: 867-879.
23. Fu, G., Haywood, M. E. and Morley, B. J., Representational difference analysis in a lupus-prone mouse strain results in the identification of an unstable region of the genome on chromosome 11. Nucleic Acids Res. 2002. 30: 1394-1400.
24. Stegalkina, S. S., Guerrero, A., Walton, K. D., Liu, X., Robinson, G. W. and Hennighausen, L., Transcription originating in the long terminal repeats of the endogenous mouse mammary tumor virus MTV-3 is activated in Stat5a-null mice and picks Up hitchhiking exons. J. Virol. 1999. 73: 8669-8676.
25. Sokol, M., Wabl, M., Ruiz, I. R. and Pedersen, F. S., Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors. Retrovirology 2014. 11: 36.
26. Hennet, T., Chui, D., Paulson, J. C. and Marth, J. D., Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA 1998. 95: 4504-4509.
27. Samardzic, T., Marinkovic, D., Danzer, C. P., Gerlach, J., Nitschke, L. and Wirth, T., Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol. 2002. 32: 561-567.
28. Cariappa, A., Takematsu, H., Liu, H., Diaz, S., Haider, K., Boboila, C., Kalloo, G. et al., B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J. Exp. Med. 2009. 206: 125-138.
29. Schuster, H., Martin, T., Marcellin, L., Garaud, J. C., Pasquali, J. L. and Korganow, A. S., Expansion of marginal zone B cells is not sufficient for the development of renal disease in NZBxNZW F1 mice. Lupus 2002. 11: 277-286.
30. Duong, B. H., Tian, H., Ota, T., Completo, G., Han, S., Vela, J. L., Ota, M. et al., Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J. Exp. Med. 2010. 207: 173-187.
31. Okeoma, C. M., Lovsin, N., Peterlin, B. M. and Ross, S. R., APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007. 445: 927-930.